Calcium Chloride

證據等級: L5

預測適應症: 0 個

Calcium Chloride: No Repurposing Predictions Currently Available

One-Sentence Summary

Calcium Chloride is an inorganic electrolyte compound with established roles in clinical practice, including management of electrolyte imbalances and cardiac emergencies. However, the current Evidence Pack contains no TxGNN-predicted new indications, and no original approved indications are recorded in this dataset. A full repurposing evaluation cannot be completed at this time — this report documents the data gaps and recommended remediation steps.

Quick Overview

Item	Content
Original Indication	Not recorded in this dataset
Predicted New Indication	None available
TxGNN Prediction Score	N/A
Evidence Level	L5 — Model prediction not yet run; no supporting studies on file
South Africa Market Status	Not marketed
Number of SAHPRA Registrations	0
Recommended Decision	Hold

Why No Prediction Is Available

The TxGNN knowledge graph repurposing model requires a valid DrugBank ID and a matched node within the knowledge graph to generate disease predictions. Although Calcium Chloride carries the DrugBank identifier DB01164, the predicted_indications array returned empty for this candidate.

This may occur for one of the following reasons:

KG node not yet mapped — Calcium Chloride may not yet be linked as an active node in the current knowledge graph build, which is common for inorganic salts and electrolytes that are not traditional small-molecule drugs.
Prediction pipeline not yet executed — The candidate may be awaiting a scheduled prediction run.
Score threshold filtering — All raw predictions may have fallen below the minimum confidence threshold applied during post-processing.

Additionally, the mechanism of action (MOA) field is marked as a data gap, preventing mechanistic reasoning that would normally support or contextualise any predictions.

Currently, detailed mechanism of action data is not available. Based on known information, Calcium Chloride is an inorganic electrolyte supplement; its clinical role in conditions such as hypocalcaemia and cardiac resuscitation is well established, but this has not been formally captured in the current dataset and cannot be used as input for prediction analysis.

Clinical Trial Evidence

Currently no related clinical trials registered for this candidate under the current Evidence Pack.

Literature Evidence

Currently no related literature available under the current Evidence Pack.

South Africa Market Information

Calcium Chloride has no SAHPRA registrations recorded in this dataset and is listed as not currently marketed in South Africa through formal registration channels.

Note: Calcium Chloride solutions are widely available globally as hospital pharmacy preparations (e.g., 10% injection) and may be used in South African public sector facilities under Essential Medicines List (EML) provisions or as unlicensed preparations — however, no formal SAHPRA product registration appears in the current data. This should be verified directly against the SAHPRA online product register.

Safety Considerations

Please refer to the SAHPRA-approved Professional Information (PI) for safety information. Report adverse drug reactions to SAHPRA via the MedSafety reporting portal.

Key safety areas to review when the PI becomes available include: hypercalcaemia risk with rapid or excessive administration, tissue necrosis with extravasation, cardiac effects (bradycardia, arrhythmia), and interactions with digoxin and calcium-channel blockers.

Conclusion and Next Steps

Decision: Hold

Rationale: The Evidence Pack for Calcium Chloride (DB01164) is critically incomplete — there are no TxGNN predictions, no original indications on record, no safety data, and no SAHPRA registrations. Proceeding to a repurposing evaluation without these foundations would not be meaningful.

To proceed, the following is needed:

Run TxGNN prediction pipeline for DB01164 — verify that Calcium Chloride is present as an active node in data/external/drugbank_vocab.csv and re-execute scripts/run_kg_prediction.py
Retrieve MOA data from the DrugBank API (DB01164) to enable mechanistic plausibility analysis
Download and parse the SAHPRA / manufacturer PI (package insert) to populate warnings, contraindications, and drug interaction data
Verify SAHPRA registration status directly via the SAHPRA online register (https://www.sahpra.org.za) — hospital-grade electrolyte preparations may appear under different naming conventions
Confirm KG node mapping — check whether “Calcium Chloride” requires synonym normalisation (e.g., “calcium dichloride”, “CaCl₂”) to match the TxGNN knowledge graph node vocabulary
Re-generate Evidence Pack once the above data gaps (DG001, DG002) are resolved and resubmit for evaluation
Disclaimer

This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.